![](/fileadmin/_processed_/csm_Electrochea_process_c40cabeed1.png)
Electrochaea sells biomethane reactor to Again A/S
Like German bio-CH4 producer Electrochea GmbH, Danish Again A/S is using CO2-fxing archaea, but to manufacture carbon-negative chemicals such...
![](/fileadmin/_processed_/csm_CordenPharma-Peptide-Expansion-Press-Release-16-July-2024-for-Web-1-1024x614_520d0c7270.jpg)
CordenPharma invests €900m in peptide patform expansion
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its peptide...
![](/fileadmin/Content/NewsAndStories/2024/National_Eye_Institute.png)
Seabelife SAS to develop next-gen dry AMD drug
French drug developer SeaBeLife SAS has bagged a €1.5m fund within the i-Nov 2024 innovation competition, which is part of the French government’s...
![](/fileadmin/_processed_/csm_SFactory01_Launch_044ec847f4.png)
Solar Foods starts Factory01
Following market authorisation in Singapore two years ago, the Finnish company Solar Foods Oy and the Japanese food giant Ajinomoto Group want to...
![](/fileadmin/_processed_/csm_LG_Draft_aece1073b5.jpg)
Locate Bio Ltd raises £9.2m venture capital
Locate Bio said it will use the fresh money to finance a clinical study of LDGraft, a bone graft substitute containing a sustained-release...
![](/fileadmin/_processed_/csm_Decoy_cell_cytology_f1d4d78e91.png)
Memo Therapeutics AG increases Series C financing to CHF45m
New investors Ysios Capital and Kurma Partners joined existing Series C round investors including Pureos Bioventures, Swisscanto, Vesalius...
![](/fileadmin/_processed_/csm_Adrenomed_cf30735df8.png)
Shock: Adrenomed AG gets FDA fast track designation
After Adrenomed AG has demonstrated that its septic shock treatment led to a 60% reduction in relative 28-day mortality vs. placebo in a stratified...